{
    "nctId": "NCT04508764",
    "briefTitle": "Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome",
    "officialTitle": "Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome",
    "overallStatus": "TERMINATED",
    "conditions": "Hereditary Breast and Ovarian Cancer, Lynch Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 96,
    "primaryOutcomeMeasure": "Proband-reported cascade testing rates of first-degree relatives",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Documentation of HBOC or Lynch-associated \"pathogenic/ likely pathogenic\" mutation per American College of Medical Genetics and Genomics criteria (1)\n* Diagnosis of one or more invasive cancers: epithelial ovarian, fallopian tube, primary peritoneal, breast, colorectal, endometrial\n* Mutation listed in NCCN guidelines with at least Category 2A evidence for intervention\n* Over the age of 18\n* Psychological ability and general health that permits completion of study requirements and follow-up\n* Willingness to complete follow-up surveys in person, electronically, or by telephone for up to 6 months\n\nExclusion Criteria:\n\n-\"Variant of undetermined significance,\" \"likely benign\" or \"benign\" variant per ACMGG criteria",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}